Literature DB >> 30956120

Fulvestrant plus anastrozole for metastatic breast cancer.

Talha Khan Burki.   

Abstract

Entities:  

Year:  2019        PMID： 30956120     DOI： 10.1016/S1470-2045(19)30217-7

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

Review 1.  Pharmacological Modulation of Steroid Activity in Hormone-Dependent Breast and Prostate Cancers: Effect of Some Plant Extract Derivatives.

Authors:  Bagora Bayala; Abdou Azaque Zoure; Silvère Baron; Cyrille de Joussineau; Jacques Simpore; Jean-Marc A Lobaccaro
Journal:  Int J Mol Sci       Date:  2020-05-23       Impact factor: 5.923

2.  Rethinking the combination treatment of fulvestrant and anastrozole for metastatic breast cancer: an integrated reanalysis of aromatase-estrogen receptor axis.

Authors:  Xing Huang
Journal:  Clin Transl Med       Date:  2019-11-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.